The Catalonian Government has authorized Avançsa to strengthen its support for the company Neos Surgery. Specifically, the Executive Council has given the green light for Avançsa to participate in the company’s capital increase, a leader in surgical medical device innovation, through the conversion of a participative loan into equity.
Avançsa has approved a new capital operation totaling one million euros, consisting of the capitalization of a previously granted 500,000-euro participative loan under the Innova Growth Line, along with an additional 500,000 euros, also in the form of equity. This decision reflects Avançsa’s confidence in Neos Surgery’s track record and future prospects as a high-tech industrial company and will accelerate the development of new products and markets.
Neos Surgery, a company already backed by Avançsa since 2020, is a Catalan technology-based firm specializing in the development and manufacture of innovative medical devices for neurosurgery, spinal surgery, and cardiothoracic surgery. Its most notable products include: Cranial LOOP® and Cranial COVER®, implantable systems for cranial closure with over ten years of experience; STERN FIX®, a next-generation device for sternal closure that has demonstrated excellent clinical results and is already marketed in 22 countries; and DISC Care®, a pioneering solution for the treatment of lumbar disc hernias, featuring a world-unique technology that has successfully passed its first human clinical trial.
cloud technology axon
Xcalibur Smart Mapping, recognised as the global leader in airborne...
